These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15998703)

  • 1. Growing old, angiotensin II, cardiac hypertrophy, and death: making the connection with p66Shc.
    Booz GW
    Hypertension; 2005 Aug; 46(2):259-60. PubMed ID: 15998703
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic deletion of the p66Shc adaptor protein protects from angiotensin II-induced myocardial damage.
    Graiani G; Lagrasta C; Migliaccio E; Spillmann F; Meloni M; Madeddu P; Quaini F; Padura IM; Lanfrancone L; Pelicci P; Emanueli C
    Hypertension; 2005 Aug; 46(2):433-40. PubMed ID: 15998704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linking inflammation and hypertension in humans: studies in Bartter's/Gitelman's syndrome patients.
    Caló LA; Davis PA; Pagnin E; Schiavo S; Semplicini A; Pessina AC
    J Hum Hypertens; 2008 Mar; 22(3):223-5. PubMed ID: 18046435
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetic cardiomyopathy: a "cardiac stem cell disease" involving p66Shc, an attractive novel molecular target for heart failure therapy.
    Messina E; Giacomello A
    Circ Res; 2006 Jul; 99(1):1-2. PubMed ID: 16825582
    [No Abstract]   [Full Text] [Related]  

  • 5. Final common molecular pathways of aging and cardiovascular disease: role of the p66Shc protein.
    Cosentino F; Francia P; Camici GG; Pelicci PG; Lüscher TF; Volpe M
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):622-8. PubMed ID: 18162611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P66shc regulates endothelial NO production and endothelium-dependent vasorelaxation: implications for age-associated vascular dysfunction.
    Yamamori T; White AR; Mattagajasingh I; Khanday FA; Haile A; Qi B; Jeon BH; Bugayenko A; Kasuno K; Berkowitz DE; Irani K
    J Mol Cell Cardiol; 2005 Dec; 39(6):992-5. PubMed ID: 16242150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p66Shc, oxidative stress and aging: importing a lifespan determinant into mitochondria.
    Pinton P; Rizzuto R
    Cell Cycle; 2008 Feb; 7(3):304-8. PubMed ID: 18235239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p66SHC: the apoptotic side of Shc proteins.
    Pellegrini M; Pacini S; Baldari CT
    Apoptosis; 2005 Jan; 10(1):13-8. PubMed ID: 15711918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory effects of the mitochondrial energetic status on mitochondrial p66Shc.
    Orsini F; Moroni M; Contursi C; Yano M; Pelicci P; Giorgio M; Migliaccio E
    Biol Chem; 2006; 387(10-11):1405-10. PubMed ID: 17081113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The heterotrimeric G q protein-coupled angiotensin II receptor activates p21 ras via the tyrosine kinase-Shc-Grb2-Sos pathway in cardiac myocytes.
    Sadoshima J; Izumo S
    EMBO J; 1996 Feb; 15(4):775-87. PubMed ID: 8631299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p66Shc is involved in promoting HIF-1alpha accumulation and cell death in hypoxic T cells.
    Carraro F; Pucci A; Pellegrini M; Pelicci PG; Baldari CT; Naldini A
    J Cell Physiol; 2007 May; 211(2):439-47. PubMed ID: 17167775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression in T-cells of the proapoptotic protein p66SHC is controlled by promoter demethylation.
    Pezzicoli A; Ulivieri C; Capitani N; Ventura A; Pelicci P; Baldari CT
    Biochem Biophys Res Commun; 2006 Oct; 349(1):322-8. PubMed ID: 16934220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of p66shc gene protects against age-related endothelial dysfunction.
    Francia P; delli Gatti C; Bachschmid M; Martin-Padura I; Savoia C; Migliaccio E; Pelicci PG; Schiavoni M; Lüscher TF; Volpe M; Cosentino F
    Circulation; 2004 Nov; 110(18):2889-95. PubMed ID: 15505103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of p66shc by melanoma inhibitory activity.
    Kasuno K; Naqvi A; Dericco J; Yamamori T; Santhanam L; Mattagajasingh I; Yang S; Meyskens FL; Bosserhoff AK; Irani K
    Cell Death Differ; 2007 Aug; 14(8):1414-21. PubMed ID: 17431427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sos-mediated activation of rac1 by p66shc.
    Khanday FA; Santhanam L; Kasuno K; Yamamori T; Naqvi A; Dericco J; Bugayenko A; Mattagajasingh I; Disanza A; Scita G; Irani K
    J Cell Biol; 2006 Mar; 172(6):817-22. PubMed ID: 16520382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of p66Shc suppresses oxidative damage in retinal pigmented epithelial cells and retina.
    Wu Z; Rogers B; Kachi S; Hackett SF; Sick A; Campochiaro PA
    J Cell Physiol; 2006 Dec; 209(3):996-1005. PubMed ID: 16972253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant mice live longer.
    Guarente L
    Nature; 1999 Nov; 402(6759):243, 245. PubMed ID: 10580490
    [No Abstract]   [Full Text] [Related]  

  • 18. Phosphorylation of p66Shc and forkhead proteins mediates Abeta toxicity.
    Smith WW; Norton DD; Gorospe M; Jiang H; Nemoto S; Holbrook NJ; Finkel T; Kusiak JW
    J Cell Biol; 2005 Apr; 169(2):331-9. PubMed ID: 15837797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: role of heparin-binding epidermal growth factor.
    Shah BH; Yesilkaya A; Olivares-Reyes JA; Chen HD; Hunyady L; Catt KJ
    Mol Endocrinol; 2004 Aug; 18(8):2035-48. PubMed ID: 15143154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway.
    Migliaccio E; Mele S; Salcini AE; Pelicci G; Lai KM; Superti-Furga G; Pawson T; Di Fiore PP; Lanfrancone L; Pelicci PG
    EMBO J; 1997 Feb; 16(4):706-16. PubMed ID: 9049300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.